City

Bristol (1)

Chapel Hill (1)

Chicago (1)

Kingston (1)

Overall Status

Recruiting (2)

Unknown status (2)

Completed (1)

Phase

n/a (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Assiut University (1)

The University of The West Indies (1)

UK Kidney Association (1)

University of Illinois at Chicago (1)

University of North Carolina, Chapel Hill (1)

Collaborator

Caribbean Health Research Council (1)

Global Blood Therapeutics (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Intervention

atorvastatin (1)

enalapril (1)

n-acetylcysteine (1)

patient with sickle cell disease (1)

placebo (1)

voxelotor (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Other (5)

Study Type

Interventional (3)

Observational (1)

Observational [Patient Registry] (1)

sickle cell nephropathy

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting

Adenine Phosphoribosyltransferase Deficiency
+83 more

Bristol, South West, United Kingdom

Zoe Plummer

Sep 26, 2023

Sickle Cell Disease, Sickle Cell Nephropathy Trial in Chicago (Voxelotor)

Recruiting

Sickle Cell Disease
Sickle Cell Nephropathy

Voxelotor

Chicago, Illinois

University of Illinois

Jun 16, 2022

Sickle Cell Disease, Sickle Cell Nephropathy Trial in Chapel Hill (Atorvastatin, Placebo)

Completed

Has Results

Sickle Cell Disease
Sickle Cell Nephropathy

Atorvastatin
Placebo

Chapel Hill, North Carolina

UNC School of Medicine Clinical&Translational Research Ctr

Mar 16, 2020

Nephropathy in Patients With Sickle Cell Disease

Unknown status

Sickle Cell Nephropathy

patient with sickle cell disease

(no location specified)

Nov 27, 2019

Microalbuminuria, Sickle Cell Nephropathy Trial in Kingston (Enalapril, N-Acetylcysteine)

Unknown status

Microalbuminuria
Sickle Cell Nephropathy

Kingston, Jamaica

Sickle Cell Unit

Jun 27, 2013